Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England's experience

Elise Tessier; Michael Edelstein; Camille Tsang; Freja Kirsebom; Charlotte Gower; Colin N.J. Campbell; Mary Ramsay; Joanne White; Nick Andrews; Jamie Lopez-Bernal; Julia Stowe

doi:10.1016/j.ijmedinf.2022.104974

Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England's experience

Elise Tessier^*
, Michael Edelstein
, Camille Tsang
, Freja Kirsebom
, Charlotte Gower
, Colin N.J. Campbell
, Mary Ramsay
, Joanne White
, Nick Andrews
, Jamie Lopez-Bernal
, Julia Stowe

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

23 Citations (Scopus)

183 Downloads (Pure)

Abstract

Background: In England routine vaccinations are recorded in either the patients General Practice record or in series of sub-national vaccine registers that are not interoperable. During the COVID-19 pandemic it was established that COVID vaccines would need to be delivered in multiple settings where current vaccine registers do not exist. We describe how a national vaccine register was created to collect data on COVID-19 vaccines.

Methods: The National Immunisation Management System (NIMS) was developed by a range of health and digital government agencies. Vaccinations delivered are entered on an application which is verified by individual National Health Service number in a centralised system. UKHSA receive a feed of this data to use for monitoring vaccine coverage, effectiveness, and safety. To validate the vaccination data, we compared vaccine records to self-reported vaccination dose, manufacturer, and vaccination date from the enhanced surveillance system from 11 February 2021 to 24 August 2021.

Results: With the Implementation of NIMS, we have been able to successfully record COVID-19 vaccinations delivered in multiple settings. Of 1,129 individuals, 97.8% were recorded in NIMS as unvaccinated compared to those who self-reported as unvaccinated. One hundred percent and 99.3% of individuals recorded in NIMS as having at least one dose and two doses of the COVID-19 vaccine were also self-reported as having at least one and two doses, respectively. Of the 100% reporting at least one dose, 98.3% self-reported the same vaccination date as NIMS. A total of 98.8% and 99.3% had the same manufacturer information for their first dose and second dose as that which was self-reported, respectively.

Discussion: Daily access to individual-level vaccine data from NIMS has allowed UKHSA to estimate vaccine coverage and provide some of the world's first vaccine effectiveness estimates rapidly and accurately.

Original language	English
Article number	104974
Journal	International Journal of Medical Informatics
Volume	170
Early online date	23 Dec 2022
DOIs	https://doi.org/10.1016/j.ijmedinf.2022.104974
Publication status	Published - Feb 2023

Bibliographical note

Funding Information: There was no external funding for this study.

Open Access: This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).

Publisher Copyright: Crown Copyright © 2022 Published by Elsevier B.V

Citation: Elise Tessier, Michael Edelstein, Camille Tsang, Freja Kirsebom, Charlotte Gower, Colin N.J. Campbell, Mary Ramsay, Joanne White, Nick Andrews, Jamie Lopez-Bernal, Julia Stowe, Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England’s experience,
International Journal of Medical Informatics, Volume 170, 2023, 104974, ISSN 1386-5056, https://doi.org/10.1016/j.ijmedinf.2022.104974.

DOI: https://doi.org/10.1016/j.ijmedinf.2022.104974.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

COVID-19
Immunisation(s)
Vaccine coverage
Vaccine registry
Vaccine uptake
Vaccine(s)

Access to Document

10.1016/j.ijmedinf.2022.104974Licence: CC BY-NC-ND

Tessier2023MonitoringTheCOVID-19ImmunisationProgrammeThroughANationalImmunisationManagementSystemIntJMedInformFinal published version, 1 MBLicence: CC BY-NC-ND

Cite this

Tessier, E., Edelstein, M., Tsang, C., Kirsebom, F., Gower, C., Campbell, C. N. J., Ramsay, M., White, J., Andrews, N., Lopez-Bernal, J., & Stowe, J. (2023). Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England's experience. International Journal of Medical Informatics, 170, Article 104974. https://doi.org/10.1016/j.ijmedinf.2022.104974

@article{8b3db331ee3445358e32205b8281cf4b,

title = "Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England's experience",

abstract = "Background: In England routine vaccinations are recorded in either the patients General Practice record or in series of sub-national vaccine registers that are not interoperable. During the COVID-19 pandemic it was established that COVID vaccines would need to be delivered in multiple settings where current vaccine registers do not exist. We describe how a national vaccine register was created to collect data on COVID-19 vaccines. Methods: The National Immunisation Management System (NIMS) was developed by a range of health and digital government agencies. Vaccinations delivered are entered on an application which is verified by individual National Health Service number in a centralised system. UKHSA receive a feed of this data to use for monitoring vaccine coverage, effectiveness, and safety. To validate the vaccination data, we compared vaccine records to self-reported vaccination dose, manufacturer, and vaccination date from the enhanced surveillance system from 11 February 2021 to 24 August 2021. Results: With the Implementation of NIMS, we have been able to successfully record COVID-19 vaccinations delivered in multiple settings. Of 1,129 individuals, 97.8\% were recorded in NIMS as unvaccinated compared to those who self-reported as unvaccinated. One hundred percent and 99.3\% of individuals recorded in NIMS as having at least one dose and two doses of the COVID-19 vaccine were also self-reported as having at least one and two doses, respectively. Of the 100\% reporting at least one dose, 98.3\% self-reported the same vaccination date as NIMS. A total of 98.8\% and 99.3\% had the same manufacturer information for their first dose and second dose as that which was self-reported, respectively. Discussion: Daily access to individual-level vaccine data from NIMS has allowed UKHSA to estimate vaccine coverage and provide some of the world's first vaccine effectiveness estimates rapidly and accurately.",

keywords = "COVID-19, Immunisation(s), Vaccine coverage, Vaccine registry, Vaccine uptake, Vaccine(s)",

author = "Elise Tessier and Michael Edelstein and Camille Tsang and Freja Kirsebom and Charlotte Gower and Campbell, \{Colin N.J.\} and Mary Ramsay and Joanne White and Nick Andrews and Jamie Lopez-Bernal and Julia Stowe",

note = "Funding Information: There was no external funding for this study. Open Access: This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Publisher Copyright: Crown Copyright {\textcopyright} 2022 Published by Elsevier B.V Citation: Elise Tessier, Michael Edelstein, Camille Tsang, Freja Kirsebom, Charlotte Gower, Colin N.J. Campbell, Mary Ramsay, Joanne White, Nick Andrews, Jamie Lopez-Bernal, Julia Stowe, Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England{\textquoteright}s experience, International Journal of Medical Informatics, Volume 170, 2023, 104974, ISSN 1386-5056, https://doi.org/10.1016/j.ijmedinf.2022.104974. DOI: https://doi.org/10.1016/j.ijmedinf.2022.104974.",

year = "2023",

month = feb,

doi = "10.1016/j.ijmedinf.2022.104974",

language = "English",

volume = "170",

journal = "International Journal of Medical Informatics",

issn = "1386-5056",

publisher = "Elsevier Ireland Ltd",

}

Tessier, E, Edelstein, M, Tsang, C, Kirsebom, F, Gower, C, Campbell, CNJ , Ramsay, M, White, J, Andrews, N , Lopez-Bernal, J & Stowe, J 2023, 'Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England's experience', International Journal of Medical Informatics, vol. 170, 104974. https://doi.org/10.1016/j.ijmedinf.2022.104974

TY - JOUR

T1 - Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England's experience

AU - Tessier, Elise

AU - Edelstein, Michael

AU - Tsang, Camille

AU - Kirsebom, Freja

AU - Gower, Charlotte

AU - Campbell, Colin N.J.

AU - Ramsay, Mary

AU - White, Joanne

AU - Andrews, Nick

AU - Lopez-Bernal, Jamie

AU - Stowe, Julia

N1 - Funding Information: There was no external funding for this study. Open Access: This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Publisher Copyright: Crown Copyright © 2022 Published by Elsevier B.V Citation: Elise Tessier, Michael Edelstein, Camille Tsang, Freja Kirsebom, Charlotte Gower, Colin N.J. Campbell, Mary Ramsay, Joanne White, Nick Andrews, Jamie Lopez-Bernal, Julia Stowe, Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England’s experience, International Journal of Medical Informatics, Volume 170, 2023, 104974, ISSN 1386-5056, https://doi.org/10.1016/j.ijmedinf.2022.104974. DOI: https://doi.org/10.1016/j.ijmedinf.2022.104974.

PY - 2023/2

Y1 - 2023/2

N2 - Background: In England routine vaccinations are recorded in either the patients General Practice record or in series of sub-national vaccine registers that are not interoperable. During the COVID-19 pandemic it was established that COVID vaccines would need to be delivered in multiple settings where current vaccine registers do not exist. We describe how a national vaccine register was created to collect data on COVID-19 vaccines. Methods: The National Immunisation Management System (NIMS) was developed by a range of health and digital government agencies. Vaccinations delivered are entered on an application which is verified by individual National Health Service number in a centralised system. UKHSA receive a feed of this data to use for monitoring vaccine coverage, effectiveness, and safety. To validate the vaccination data, we compared vaccine records to self-reported vaccination dose, manufacturer, and vaccination date from the enhanced surveillance system from 11 February 2021 to 24 August 2021. Results: With the Implementation of NIMS, we have been able to successfully record COVID-19 vaccinations delivered in multiple settings. Of 1,129 individuals, 97.8% were recorded in NIMS as unvaccinated compared to those who self-reported as unvaccinated. One hundred percent and 99.3% of individuals recorded in NIMS as having at least one dose and two doses of the COVID-19 vaccine were also self-reported as having at least one and two doses, respectively. Of the 100% reporting at least one dose, 98.3% self-reported the same vaccination date as NIMS. A total of 98.8% and 99.3% had the same manufacturer information for their first dose and second dose as that which was self-reported, respectively. Discussion: Daily access to individual-level vaccine data from NIMS has allowed UKHSA to estimate vaccine coverage and provide some of the world's first vaccine effectiveness estimates rapidly and accurately.

AB - Background: In England routine vaccinations are recorded in either the patients General Practice record or in series of sub-national vaccine registers that are not interoperable. During the COVID-19 pandemic it was established that COVID vaccines would need to be delivered in multiple settings where current vaccine registers do not exist. We describe how a national vaccine register was created to collect data on COVID-19 vaccines. Methods: The National Immunisation Management System (NIMS) was developed by a range of health and digital government agencies. Vaccinations delivered are entered on an application which is verified by individual National Health Service number in a centralised system. UKHSA receive a feed of this data to use for monitoring vaccine coverage, effectiveness, and safety. To validate the vaccination data, we compared vaccine records to self-reported vaccination dose, manufacturer, and vaccination date from the enhanced surveillance system from 11 February 2021 to 24 August 2021. Results: With the Implementation of NIMS, we have been able to successfully record COVID-19 vaccinations delivered in multiple settings. Of 1,129 individuals, 97.8% were recorded in NIMS as unvaccinated compared to those who self-reported as unvaccinated. One hundred percent and 99.3% of individuals recorded in NIMS as having at least one dose and two doses of the COVID-19 vaccine were also self-reported as having at least one and two doses, respectively. Of the 100% reporting at least one dose, 98.3% self-reported the same vaccination date as NIMS. A total of 98.8% and 99.3% had the same manufacturer information for their first dose and second dose as that which was self-reported, respectively. Discussion: Daily access to individual-level vaccine data from NIMS has allowed UKHSA to estimate vaccine coverage and provide some of the world's first vaccine effectiveness estimates rapidly and accurately.

KW - COVID-19

KW - Immunisation(s)

KW - Vaccine coverage

KW - Vaccine registry

KW - Vaccine uptake

KW - Vaccine(s)

UR - https://www.scopus.com/pages/publications/85144611205

U2 - 10.1016/j.ijmedinf.2022.104974

DO - 10.1016/j.ijmedinf.2022.104974

M3 - Article

C2 - 36577202

AN - SCOPUS:85144611205

SN - 1386-5056

VL - 170

JO - International Journal of Medical Informatics

JF - International Journal of Medical Informatics

M1 - 104974

ER -

Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England's experience

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this